Contributions to the study of morphofunctional interrelations in the liver of the rats treated with certain antipsychotic drugs

Romanian Journal of Morphology and Embryology

Volumn 52, Issue SUPPL. 1, 2011, Pages 465-469

  Bogdan, Maria ^a   Popescu, Florica ^a   Bogdan, F L ^a  

^a UNIVERSITY OF MEDICINE AND PHARMACY OF CRAIOVA   (Romania)

Author keywords

Antipsychotic drugs; Liver toxicity

Indexed keywords

CHLORPROMAZINE; HALOPERIDOL; NEUROLEPTIC AGENT; RISPERIDONE;

ANIMAL; ARTICLE; DRUG EFFECT; LIVER; MALE; PATHOLOGY; RAT; WISTAR RAT;

ANIMALS; ANTIPSYCHOTIC AGENTS; CHLORPROMAZINE; HALOPERIDOL; LIVER; MALE; RATS; RATS, WISTAR; RISPERIDONE;

RATTUS;

EID: 79953142868     PISSN: 12200522     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. th edition, McGraw-Hill Professional, New York, 2001, 17:361-393; 25, 26:581-616; 27:617-657.
2. OLFSON M, MARCUS SC, COREY-LISLE P, TUOMARI AV, HINES P, L'ITALIEN GJ, Hyperlipidemia following treatment with antipsychotic medication, Am J Psychiatry, 2006, 163(10):1821-1825.
3. HADDAD PM, Antipsychotics and diabetes: review of nonprospective data, Br J Psychiatry Suppl, 2004, 47:S80-S86.
4. LEUCHT S, CORVES C, ARBTER D, ENGEL RR, LI C, DAVIS JM, Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis, Lancet, 2009, 373(9657):31-41.
5. OLOFINJANA B, TAYLOR D, Antipsychotic drugs - information and choice: a patient survey, Psychiatr Bull, 2005, 29(10):369-371.
6. LIEBERMAN JA, STROUP TS, MCEVOY JP, SWARTZ MS, ROSENHECK RA, PERKINS DO, KEEFE RSE, DAVIS SM, DAVIS CE, LEBOWITZ BD, SEVERE J, HSIAO JK; CLINICAL ANTIPSYCHOTIC TRIALS OF INTERVENTION EFFECTIVENESS (CATIE) INVESTIGATORS, Effectiveness of antipsychotics drugs in patients with chronic schizophrenia, N Engl J Med, 2005, 353(12):1209-1223.
7. DAVIS JM, CHEN N, GLICK ID, A meta-analysis of the efficacy of second-generation antipsychotics, Arch Gen Psychiatry, 2003, 60(6):553-564.
8. COHN TA, SERNYAK MJ, Metabolic monitoring for patients treated with antipsychotic medications, Can J Psychiatry, 2006, 51(8):492-501.
9. SMITH M, HOPKINS D, PEVELER RC, HOLT RIG, WOODWARD M, ISMAIL K, First- versus second-generation antipsychotics and risk for diabetes in schizophrenia: systematic review and meta-analysis, Br J Psychiatry, 2008, 192(6):406-411.
10. RETTENBACHER MA, EBENBICHLER C, HOFER A, KEMMLER G, BAUMGARTNER S, EDLINGER M, HUMMER M, LECHLEITNER M, FLEISCHHACKER WW, Early changes of plasma lipids during treatment with atypical antipsychotics, Int Clin Psychopharmacol, 2006, 21(6):369-372.
11. MEYER JM, Novel antipsychotics and severe hyperlipidemia, J Clin Psychopharmacol, 2001, 21(4):369-374.
12. LI J, NIU JZ, WANG JF, LI Y, TAO XH, Pathological mechanisms of alcohol-induced hepatic portal hypertension in early stage fibrosis rat model, World J Gastroenterol, 2005, 11(41):6483-6488.
13. GORRELL MD, WANG XM, LEVY MT, KABLE E, MARINOS G, COX G, MCCAUGHAN GW, Intrahepatic expression of collagen and fibroblast activation protein (FAP) in hepatitis C virus infection, Adv Exp Med Biol, 2003, 524:235-243.
14. DELEVE LD, SHULMAN HM, MCDONALD GB, Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (venoocclusive disease, Semin Liver Dis, 2002, 22(1):27-42.
15. KNITTEL T, SCHUPPAN D, MEYER ZUM BÜSCHENFELDE KH, RAMADORI G, Differential expression of collagen types I, III, and IV by fat-storing (Ito) cells in vitro, Gastroenterology, 1992, 102(5):1724-1735.
16. MOREIRA RK, Hepatic stellate cells and liver fibrosis, Arch Pathol Lab Med, 2007, 131(11):1728-1734.
17. KISSELEVA T, BRENNER DA, Hepatic stellate cells and the reversal of fibrosis, J Gastroenterol Hepatol, 2006, 21 Suppl 3:S84-S87.
18. XU GF, WANG XY, GE GL, LI PT, JIA X, TIAN DL, JIANG LD, YANG JX, Dynamic changes of capillarization and perisinusoid fibrosis in alcoholic liver diseases, World J Gastroenterol, 2004, 10(2):238-243.
19. BO AH, TIAN CS, XUE GP, DU JH, XU YL, Morphology of immune and alcoholic liver diseases in rats, Shijie Huaren Xiaohua Zazhi, 2001, 9:157-160.
20. WANG LT, ZHANG B, CHEN JJ, Effect of anti-fibrosis compound on collagen expression of hepatic cells in experimental liver fibrosis of rats, World J Gastroenterol, 2000, 6(6):877-880.
21. LE BOUSSE-KERDILÈS MC, MARTYRÉ MC, SAMSON M, Cellular and molecular mechanisms underlying bone marrow and liver fibrosis: a review, Eur Cytokine Netw, 2008, 19(2):69-80.
22. ZHOU YJ, YAO HQ, WANG J, WANG H, CHEN YC, Influence of spleen-firming therapeutics on collagen fibers of hepatic fibrosis rat, J Chinese Clin Med, 2008, 3(2):82-86.